patients with asymptomatic active brain metastases from small cell lung cancer research hub

A single arm phase II study evaluating intracranial efficacy of tarlatamab in patients with asymptomatic active brain metastases from small cell lung cancer

This study is looking at a new treatment called Tarlatamab for people with small cell lung cancer that has spread to the brain. It aims to see how well the treatment shrinks brain tumours and controls the cancer without causing symptoms.